ロード中...
Can the Orexin Antagonist Suvorexant Preserve the Ability to Awaken to Auditory Stimuli While Improving Sleep?
STUDY OBJECTIVES: The safety profile of the dual orexin receptor antagonists (DORAs) are currently unknown with regard to nocturnal responsivity among people with insomnia. We compared the auditory awakening thresholds (AATs) of the DORA suvorexant (10 and 20 mg) versus placebo in 12 individuals wit...
保存先:
| 出版年: | J Clin Sleep Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Academy of Sleep Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6760418/ https://ncbi.nlm.nih.gov/pubmed/31538599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5664/jcsm.7920 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|